XCUR-17

N/A

Report date: 2022/02/07 16:38:29

NME

Base Information

Drug NameXCUR-17

Drug Alias NameXCUR-17

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense

Mechanisms of ActionInterleukin-17 receptor A antagonists

TargetsInterleukin-17 receptor A

Therapy Area/IndicationsPsoriasis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesExicure Inc

China Registration ClassN/A

Active CompaniesExicure Inc

Inactive CompaniesN/A

Active IndicationsPsoriasis

Inactive IndicationsN/A

ATC CodeN/A